Maria Palasis, President & CEO: Lyra Therapeutics LYRA Sell · Filed 01/08

Trade details

Type: Insider sale
Amount: $5,718.72
Shares · price: 1,702 sh · $3.36 a share
Held after: 1,096,733 sh
Stock: Lyra Therapeutics LYRA
Person: Maria PalasisPresident & CEO
Trade date: 26/01/06
Filed: 26/01/08
Days to filing: 2 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Lyra Therapeutics trades, last 26 weeks

What else happened in Lyra Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/07~02/05

Maria Palasis's recent trades

Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$26.6K
906 sh
$26.6K
Filed 25/12/02
Traded 25/12/01
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$15K
500 sh
$15K
Filed 25/12/02
Traded 25/12/01
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$34.6K
1,287 sh
$34.6K
Filed 25/11/05
Traded 25/10/31
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$3,267
119 sh
$3,267
Filed 25/11/05
Traded 25/10/31
Maria PalasisDirector
Planned sale10b5-1 planBeta Bionics
Planned sale10b5-1 plan
Beta Bionics
BBNX
$75.3K
2,812 sh
$75.3K
Filed 25/10/31
Traded 25/10/31

Maria Palasis, CEO — sold $5,719 of Lyra Therapeutics LYRA · 0.2% of holdings · 10b5-1 plan | Whalegun